Multimedia Available: Study Shows Alustra More Than Twice As Effective As Tretinoin In Treating Melasma

Medicis Pharmaceutical Corporation (NYSE:MRX) announced a recently completed study shows that its ALUSTRA(tm) (hydroquinone USP 4%) cream is twice as effective in treating melasma as topical tretinoin (Renova(R) 0.05%). Hydroquinone and tretinoin are the most popularly prescribed medications for melasma, the darkening of skin pigmentation around the cheeks and forehead, often referred to as "the mask of pregnancy." Melasma can also be caused by other changes in female hormones, including the use of birth control pills.

You can reach the story directly by going to http://www.newstream.com/cgi-bin/display_story.cgi?5585

This multimedia news story is for free and unrestricted use on your news information site (and for print or broadcast too). Visit http://www.newstream.com to download video, audio, text, graphics, and photos.

If you have any questions about the story, or about Newstream.com, please write to us at info@newstream.com.

NOTE TO EDITORS: Multimedia Assets Available With This Story

Include Logos, Photos, Text News Releases

Contacts:

Newstream.com, New York
info@newstream.com